Todd Waldman: We have a post-doctoral position available in my lab to study the function of the STAG2 tumor suppressor gene in the pathogenesis of human cancer.
Quoting Todd Waldman, Professor of Oncology, Molecular Biology, and Genetics and Director of the MD/PhD Program at Georgetown University School of Medicine, on LinkedIn:
”We have a post-doctoral position available in my lab to study the function of the STAG2 tumor suppressor gene in the pathogenesis of human cancer. Inactivating mutations in STAG2 are common in Ewing sarcoma, bladder cancer, myeloid leukemias, brain cancers, and other tumor types. STAG2 is a regulatory component of the cohesin complex, which is an engine for generating chromatin loops. However, how aberrant regulation of chromatin loop extrusion causes cancer is a complete and fascinating mystery. If interested, please contact me at [email protected]. Please consider forwarding this post to your networks. Thanks!”
Source: Todd Waldman/LinkedIn
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023